Back to Newsroom

Syndax Announces Appointment of Richard P. Shea as Independent Director and Chair of the Audit Committee

WALTHAM, Mass., Jan. 23, 2014 – Syndax Pharmaceuticals, Inc. today announced the appointment of Richard P. Shea to its board of directors as an independent director and chairman of the audit committee. Mr. Shea is an experienced biotechnology executive with wide ranging experience in finance and operations as well as managing venture financings, initial public offerings, secondary offerings and mergers and acquisitions.